News

Patient-reported outcomes data can help FDA reviewers decide whether to approve a drug, but applications seeking marketing approval frequently lack them. FDA’s Efforts Through its Patient ...
The trial has two independent main goals 1) a Patient-Reported Outcome (PRO), as guided by the FDA, and 2) lung density measured by CT scan, as guided by the EMA.
MASH Companies are Boehringer Ingelheim, Hepagene, Eli Lilly and Company, Hepion Pharmaceuticals, Ionis Pharmaceuticals, Galectin Therapeutics, Novo Nordisk A/S, Merck & Co., Zealand Pharma, Hanmi ...
WALTHAM, Mass. and BOULDER, Colo., June 27, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically ...
New Patient-Reported Outcomes from UGN-102 Clinical Trials Show the Investigational ... for UGN-102 in August 2024, ahead of schedule. The FDA accepted the NDA for UGN-102 and assigned a ...
Only a minority of the instruments used in clinical and research settings to evaluate patient-reported outcome measures (PROMs) in CVD care adhere to quality standards set by the US Food and Drug ...
CHICAGO — Patient-reported outcomes collected through an electronic health record-integrated symptom management program did not significantly reduce ED or inpatient admission events after cancer ...
Patient-reported outcomes (PROs) specifically capture the patient’s direct perspective on disease burden, treatment effects, daily functioning, and overall well-being.
Exhibit 4 Summary of outcomes reported in a systematic review of studies on Food and Drug Administration (FDA) black-box warnings on youth antidepressant medications, 2007–17 Distinct outcomes ...
As part of our commitment, we've once again partnered with Statista, Inc. to evaluate the implementation of Patient Reported Outcome Measures (PROMs) in the leading hospitals around the world.
Healio spoke with Darin Messina, PhD, on the significance and practical impact of the FDA’s most recent approval of Botox Cosmetic for platysma bands. As Healio previously reported, the FDA ...
Credit: Getty Images. The FDA encourages collection and reporting of patient-reported outcomes (PROs) in clinical trials, but a substantial proportion of applications seeking product approval lack ...